 - Use of systemic estrogens andor progestogens including intra-uterine progestogen therapy andor tibolone andor phytoestrogens within 8 weeks prior to baseline; use of transdermal hormone therapy andor local estrogen applications andor non-hormonal medication for vasomotor symptoms within 4 weeks prior to baseline. 